L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.
PKvitality is developing K'Watch Glucose, a painless Continuous Glucose Monitoring device in a form of a smartwatch. Completely invisible to others, K'Watch will help diabetics to better control their disease and check their glucose level discreetly.
Paris, Île-de-France, France
Envoyer un message
PKvitality, has been selected to join the 1st promotion of Future4care, the largest eHealth accelerator in Europe. At the forefront of diabetes innovation, PKvitality has developed K’Watch Glucose, the world’s first Continuous Glucose Monitoring (CGM) smartwatch. The acceleration will speed up the development of this unique innovation in diabetes monitoring that takes the form of a smartwatch.
Future4care is Europe’s largest open-innovation ecosystem on healthcare created under the initiative of four leading companies: Capgemini, Generali, Orange, and Sanofi. Its ambition is to support emerging companies in bringing their solutions to market and to accelerate future of healthcare for patients, by making the most of the possibilities of digital technology.
Visit the K’Watch Glucose to learn more.
PKvitality officially attended Europe’s most anticipated conference on Advanced Technologies and Treatments for Diabetes (ATTD) – from April 27-30, 2022, in Barcelona.
On this occasion, the results of the First-In-Human Clinical Trials of K’Watch Glucose have been presented in an e-poster by Timothy Bailey, Principal Investigator of the trial and CEO of AMCR Institute. These clinical results will be explained, on-site, by Minh Lê, General Manager of PKvitality.
The trials led by PKvitality were successful and showed great user experience and tracking. The trial took place at AMCR Institute, a clinical research center focused on diabetes and obesity with worldwide renowned medical device expertise in the metabolic area. Non-invasive, precise and affordable, K’Watch will change the everyday lives of diabetics!
Munich, 28 April 2021 - Among the 160 start-up candidates, PKvitality is one of the 5 start-ups to have been awarded. PKvitality was co-winner of the 12th edition of the IoT Innovation World Cup in the medical category. The IoT Innovation World Cup is a global competition that brings together over 600 start-ups for a competition based on technological innovation.
Paris, November 23, 2020 - PKvitality was rewarded by being named the world’s No. 1 “Internet of Medical Things Techpreneurs 2020” at the 12th Healthcare Innovation World Cup 2020 held during the Medica exhibition. It was at the Medica Connected Healthcare Forum that PKvitality was able to stand out among more than 120 competing solutions from around the world.
Paris, September 10th, 2020 – PKvitality, a French company specialized in bio-wearables, is laureate of the EIC Accelerator program of the European Union. The earned grant of €2.289k will finance the development of K’Watch Glucose, a Continuous Glucose Monitor (CGM) in the form of a smartwatch.
Débute le 2016
First results of in vivo tests on pigs
CES presence: 6 awards including 1 BEST OF INNOVATION in "Tech for a better world" category
Laureate EIC accelerator, blended financing (2.3m€ grant, 5m€ equity)
First in Human results proving high accuracy and excellent tolerance